SCHEMBL18392866

SCHEMBL18392866

C=C/C(=C\C)Nc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TGM2 P21980 2/20 0.55
▸ TAS2R38 P59533 3/20 0.45
▸ HSD17B10 Q99714 3/20 0.45
▸ NAPRT Q6XQN6 1/20 0.45
▸ TP53 P04637 2/20 0.43
▸ TSHR P16473 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ EPHX1 P07099 1/20 0.43
▸ EPHX2 P34913 1/20 0.43
▸ CDK9 P50750 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ CLK4 Q9HAZ1 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP1A2 P05177 2/20 0.42
▸ GAA P10253 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19546741 0.88 PTPN1 (0.47) TGM2ALDH1A1SMN1; SMN2MAPTKDM4E
SCHEMBL20008068 0.83 TGM2 (0.47) TGM2TAS2R38HSD17B10NAPRTTP53
SCHEMBL15292671 0.83 TGM2 (0.47) TGM2TAS2R38HSD17B10NAPRTTP53
SCHEMBL26614377 0.83 TGM2 (0.47) TGM2TAS2R38HSD17B10NAPRTTP53
SCHEMBL18383509 0.81 TGM2 (0.53) TGM2TAS2R38HSD17B10NAPRTTP53
SCHEMBL24636727 0.80 TGM2 (0.48) TGM2TAS2R38HSD17B10NAPRTTP53
SCHEMBL19057796 0.80 TGM2 (0.44) TGM2TAS2R38HSD17B10NAPRTTP53
SCHEMBL14402892 0.80 TGM2 (0.48) TGM2TAS2R38HSD17B10NAPRTTP53
SCHEMBL20433894 0.80 TGM2 (0.53) TGM2HSD17B10NAPRTTP53TSHR
SCHEMBL25516100 0.79 MDM2 (0.47) EPHX1SMN1; SMN2GAAKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210040369-A1 Heat Transfer Fluids and Methods of Use EXXONMOBIL RES & ENG CO (US) 2021-02-11 — — US disclosed
EP-3405554-B1 LUBRICATING OIL COMPOSITION CONTAINING A MIXTURE OF OLEFIN COPOLYMER DISPERSANT-TYPE VISCOSITY IMPROVER AND AMINE COMPOUND CHEVRON ORONITE CO (US) 2019-12-25 — — EP disclosed
WO-2017127637-A1 SYNERGISTIC LUBRICATING OIL COMPOSITION CONTAINING A MIXTURE OF OLEFIN COPOLYMER DISPERSANT-TYPE VISCOSITY IMPROVER AND AMINE COMPOUND CHEVRON ORONITE COMPANY LLC (US) 2017-07-27 — — WO disclosed
US-20170015618-A1 DIARYL AMINE ANTIOXIDANTS PREPARED FROM BRANCHED OLEFINS LANXESS CORPORATION 2017-01-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170015618-A1 DIARYL AMINE ANTIOXIDANTS PREPARED FROM BRANCHED OLEFINS AOC2, AOC3, SOD1 TGM2 979/4885TAS2R38 2620/4885HSD17B10 328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback